Taro Pharmaceutical Industries Ltd (TARO) - Financial and Strategic SWOT Analysis Review

1 of 5

FEATURED COMPANIES

  • Bayer Inc
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • MORE
Taro Pharmaceutical Industries Ltd (TARO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled the Author to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Taro Pharmaceutical Industries Ltd (Taro), a subsidiary of Sun Pharmaceutical Industries Ltd, research develops and markets healthcare products. The company manufactures prescription drugs, nonprescription drugs and active pharmaceutical ingredients (APIs). It develops pharmaceutical products in semi-solids formulations, such as ointments and creams and other dosage forms including liquids, capsules and tablets. Taro develops products in dermatological and topical, neuropsychiatric, anti-inflammatory and cardiovascular areas. The company sells and distributes its product to healthcare institutions, drug store chains, and private pharmacies. It has presence in Israel, the US, Canada and other countries. Taro is headquartered in Haifa Bay, Israel.

Taro Pharmaceutical Industries Ltd Key Recent Developments

Aug 09, 2018: Taro provides results for quarter ended June 2018
May 17, 2018: Taro Provides Results for Year Ended March 31, 2018
Feb 07, 2018: Taro Provides Results for December 31, 2017
Nov 07, 2017: Taro Provides Results for September 30, 2017
Sep 01, 2017: Taro Announces Joining of CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer Inc
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Novartis AG
  • MORE
Section 1 - About the Company
Taro Pharmaceutical Industries Ltd - Key Facts
Taro Pharmaceutical Industries Ltd - Key Employees
Taro Pharmaceutical Industries Ltd - Key Employee Biographies
Taro Pharmaceutical Industries Ltd - Major Products and Services
Taro Pharmaceutical Industries Ltd - History
Taro Pharmaceutical Industries Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
Taro Pharmaceutical Industries Ltd -
Business Description

Geographical Segment: Canada
Performance
Geographical Segment: Israel
Performance
Geographical Segment: Other
Performance
Geographical Segment: United States
Performance
R&D Overview
Taro Pharmaceutical Industries Ltd - SWOT Analysis
SWOT Analysis - Overview
Taro Pharmaceutical Industries Ltd - Strengths
Taro Pharmaceutical Industries Ltd - Weaknesses
Taro Pharmaceutical Industries Ltd - Opportunities
Taro Pharmaceutical Industries Ltd - Threats
Taro Pharmaceutical Industries Ltd - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD
Taro Pharmaceutical Industries Ltd, Recent Deals Summary

Section 5 – Company’s
Recent Developments

Aug 09, 2018: Taro provides results for quarter ended June
Aug 09, 2018: Taro provides results for quarter ended June
May 17, 2018: Taro Provides Results for Year Ended March 31,
Feb 07, 2018: Taro Provides Results for December 31,
Nov 07, 2017: Taro Provides Results for September 30,
Sep 01, 2017: Taro Announces Joining of CEO
Aug 08, 2017: Taro Provides Results for Quarter Ended June
May 22, 2017: Taro Provides Results for Year Ended March 31,
Feb 09, 2017: Taro Provides Results for December 31,

Section 6 –
Appendix

Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Taro Pharmaceutical Industries Ltd, Key Facts
Taro Pharmaceutical Industries Ltd, Key Employees
Taro Pharmaceutical Industries Ltd, Key Employee Biographies
Taro Pharmaceutical Industries Ltd, Major Products and Services
Taro Pharmaceutical Industries Ltd, History
Taro Pharmaceutical Industries Ltd, Subsidiaries
Taro Pharmaceutical Industries Ltd, Key Competitors
Taro Pharmaceutical Industries Ltd, Ratios based on current share price
Taro Pharmaceutical Industries Ltd, Annual Ratios
Taro Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Taro Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Taro Pharmaceutical Industries Ltd, Interim Ratios
Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD
Taro Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Taro Pharmaceutical Industries Ltd, Performance Chart (2014 - 2018)
Taro Pharmaceutical Industries Ltd, Ratio Charts
Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd
  • Rafa Laboratories Ltd
  • Pfizer Inc
  • Perrigo Company Plc
  • Novartis AG
  • Merck & Co Inc
  • GlaxoSmithKline Plc
  • Eli Lilly and Co
  • Bristol-Myers Squibb Co
  • Bayer Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll